ArticleBMC genomics2026
Decoding the genome of the basidiomycetous yeast Vishniacozyma victoriae D19: a promising fungal model for biotechnology.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundVishniacozyma victoriae is a ubiquitous yeast isolated from various regions across the globe, especially in extreme environments. It can produce several interesting extracellular compounds, including carotenoids and cold-active hydrolytic enzymes, that confer high potential for industrial production and biotechnological applications. However, insufficient knowledge in its biology, genetics and genomics are the primary obstacle of its development as a new chassis. The aim of this study was to provide a high-quality genome assembly and an in-depth genome analysis of V. victoriae strain D19.
resultsWe isolated V. victoriae D19 (CBS 19383) from Trondheimfjordens, Norway. Here we present its high-quality genome assembly, along with comprehensive structural and functional annotation of the genome. The assembly consists of 10 nuclear scaffolds with a cumulative size of 18.1 Mb, an N50 value of 1.7 Mb (L50 = 3) and a complete circular mitochondrial genome. A total of 7,853 protein-coding genes were predicted. Intron structure and other features, such as rRNA, tRNA, transposable elements, telomeric repeats were also analyzed to contribute to a deeper understanding of the V. victoriae genome architecture. Functional gene annotation, performed using the go-FAnnoT and BlastKOALA tools, enabled the reconstruction of key metabolic pathways, providing potential functions for 6,434 and 3,626 proteins, respectively. Moreover, the analysis of protein targeting and in silico secretome analysis, followed by CAZymes identification, helped us to understand the metabolic potential of this yeast.
conclusionThese genomic resources establish a valuable foundation for future functional studies and provide keys for developing a new chassis for potential industrial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.